| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 11.959 | 78.091 | 66.005 | 63.712 | 68.558 | 100.077 | 101.238 | 122.417 | 113.842 |
| Total Income - EUR | - | 11.959 | 78.093 | 66.006 | 63.712 | 70.992 | 100.077 | 101.238 | 122.417 | 117.649 |
| Total Expenses - EUR | - | 29.847 | 66.253 | 64.931 | 62.809 | 79.350 | 78.124 | 83.698 | 104.736 | 102.277 |
| Gross Profit/Loss - EUR | - | -17.888 | 11.840 | 1.075 | 904 | -8.358 | 21.953 | 17.541 | 17.681 | 15.372 |
| Net Profit/Loss - EUR | - | -18.008 | 11.068 | 415 | 267 | -8.779 | 20.953 | 16.775 | 16.604 | 12.550 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
Check the financial reports for the company - Dermo Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 47.621 | 37.548 | 26.204 | 40.832 | 41.684 | 31.083 | 21.036 | 40.539 | 32.529 |
| Current Assets | - | 2.803 | 7.597 | 11.137 | 13.860 | 13.806 | 5.362 | 22.428 | 25.496 | 38.442 |
| Inventories | - | 2.434 | 142 | 289 | 613 | 1.631 | 1.367 | 11.230 | 3.278 | 2.036 |
| Receivables | - | 0 | 4.799 | 0 | 3.389 | 2.201 | 12 | 1.615 | 2.157 | 12.549 |
| Cash | - | 369 | 2.657 | 10.849 | 9.859 | 9.973 | 3.982 | 9.583 | 20.060 | 23.857 |
| Shareholders Funds | - | -17.963 | -6.547 | -6.012 | -5.629 | -14.302 | 6.968 | 23.764 | 40.202 | 52.528 |
| Social Capital | - | 45 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 68.417 | 53.497 | 45.185 | 69.730 | 71.744 | 31.471 | 21.745 | 30.345 | 20.820 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9602 - 9602" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Dermo Line Srl